Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ARTL
#9739
Artelo Biosciences, Inc. Common Stock
3.760
0
USD
-3.59%
Settore:
Salute
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.59%
Variazione Mensile
+213.33%
Variazione di 6 mesi
+213.33%
Variazione Annuale
+213.33%
Chiusura Precedente
3.900
0
Open
3.760
0
Bid
3.760
0
Ask
3.763
0
Low
3.760
0
High
3.760
0
Volume
1
Mercati
Mercato Azionario Statunitense
Salute
ARTL
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
167.91 K
470.01 K
475.95 K
537.95 K
546.84 K
2.12 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
1.99 M
—
Price to earnings ratio
—
—
—
—
—
-0.1
—
Price to sales ratio
—
—
—
—
—
1.52
—
Price to cash flow ratio
—
—
—
—
—
0.15
—
Price to book ratio
—
—
—
—
—
0.99
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.06
0.59
0.49
0.71
2.09
4.6
3.63
Return on equity %
1.2
0.62
0.52
0.79
3.44
10.13
14.13
Return on invested capital %
786.8
—
1 810.29
1 294.02
1 204.59
1 550.51
1 555.83
Gross margin %
—
—
—
—
—
100
—
Operating margin %
—
—
—
—
—
1 382.3
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
1 561.09
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.65
19.61
18.36
8.51
1.44
0.17
1.43
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
0.22
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
0.16
—
Long term debt to total equity ratio
—
—
—
—
—
0.34
—
Per share metrics
Operating cash flow per share
—
—
—
—
15.54
8.28
11.09
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
0.47
0.58
5.26
Net current asset value per share
—
—
—
—
4.76
0.68
9.41
Tangible book value per share
—
—
—
—
1.52
-0.75
-6.17
Working capital per share
—
—
—
—
1.46
-3.25
-15.77
Book value per share
—
—
—
—
5.32
1.24
5.68
Notizie
Artelo Biosciences attua un raggruppamento azionario di 3 per 1
Artelo Biosciences implements 3-for-1 reverse stock split
Artelo Biosciences registra una perdita di 12,9 milioni di dollari per il 2025
Artelo Biosciences reports $12.9M loss for 2025
Artelo Biosciences rinvia l’assemblea annuale per mancanza di quorum
Artelo Biosciences adjourns annual meeting due to lack of quorum
Casa Bianca lancia programma pilota Medicare per rimborso CBD
White House launches Medicare pilot program for CBD reimbursement
L’inibitore FABP5 di Artelo mostra risultati promettenti per ansia e depressione
Artelo’s FABP5 inhibitor shows promise for anxiety and depression
Artelo Biosciences appoints Mark Spring as new CFO
Artelo Biosciences nomina Mark Spring come CFO e modifica accordi dirigenziali